| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.40(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,033 |
| 52
Week Range: |
$6.53 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2019-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,703 |
178,424 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2019-08-16 |
4 |
B |
$21.18 |
$650,142 |
D/D |
30,703 |
147,721 |
2.74 |
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2019-08-12 |
4 |
AS |
$22.45 |
$76,726 |
D/D |
(3,418) |
50,525 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2019-08-09 |
4 |
D |
$22.39 |
$174,172 |
D/D |
(7,779) |
53,943 |
|
- |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2019-07-11 |
4 |
AS |
$24.81 |
$98,446 |
D/D |
(3,968) |
61,722 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2019-06-28 |
4 |
A |
$25.22 |
$31,853 |
D/D |
1,263 |
86,351 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2019-06-28 |
4 |
A |
$25.22 |
$37,477 |
D/D |
1,486 |
91,014 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2019-06-28 |
4 |
A |
$25.22 |
$31,248 |
D/D |
1,239 |
271,776 |
|
- |
|
| Paulson John |
Director |
• • – |
2019-06-28 |
4 |
A |
$25.22 |
$27,490 |
D/D |
1,090 |
53,535 |
|
- |
|
| Mckenna Mark C. |
President, Salix |
• • – |
2019-06-24 |
4 |
D |
$23.82 |
$45,568 |
D/D |
(1,913) |
31,529 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2019-06-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(111,440) |
948,353 |
|
- |
|
| Eldessouky Sam |
SVP, CHIEF ACCOUNTING OFFICER |
• • – |
2019-06-04 |
4 |
D |
$20.73 |
$132,050 |
D/D |
(6,370) |
61,444 |
|
- |
|
| Gordon Joseph F |
Pres&Co-Head Bausch&Lomb/Intl |
• • – |
2019-05-06 |
4 |
D |
$23.51 |
$16,292 |
D/D |
(693) |
51,196 |
|
- |
|
| Mckenna Mark C. |
President, Salix |
• • – |
2019-05-06 |
4 |
D |
$23.51 |
$17,538 |
D/D |
(746) |
33,442 |
|
- |
|
| Kavanagh Sarah B |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
64,378 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
270,537 |
|
- |
|
| Power Robert N |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
82,742 |
|
- |
|
| Paulson John |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
52,445 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
20,518 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
89,528 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
85,088 |
|
- |
|
| Ross Thomas W. Sr. |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
76,802 |
|
- |
|
| Karabelas Argeris N |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
70,646 |
|
- |
|
| Von Eschenbach Andrew C. |
Director |
• • – |
2019-05-03 |
4 |
A |
$23.51 |
$249,982 |
D/D |
10,633 |
17,465 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2019-05-01 |
4 |
D |
$23.63 |
$94,425 |
D/D |
(3,996) |
259,904 |
|
- |
|
1049 Records found
|
|
Page 15 of 42 |
|
|
0.30 (4.24%) 
